Clinical Effects of Ozone Therapy in Cervical Disc Hernia
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03056911 |
Recruitment Status : Unknown
Verified February 2017 by Havva Sayhan, Sakarya University.
Recruitment status was: Recruiting
First Posted : February 17, 2017
Last Update Posted : February 17, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Pain, Neck | Drug: Ozone |
This is a retrospective, single-center study that is going to be conducted from November 2013 to May 2016 on patients visiting the pain clinic of the hospital who were treated with Ozone-oxygen therapy for cervical discogenic or radicular pain.
Data collected from medical record forms and electronic medical record system of the hospital were used in the retrospective analysis of medical data with regard to age, gender, complications.
A resident who has not involved in the study interviewed each patient by telephone on the follow up to collect the related information.
Study Type : | Observational |
Estimated Enrollment : | 43 participants |
Observational Model: | Other |
Time Perspective: | Retrospective |
Official Title: | Clinical Effects of Ozone Therapy in Cervical Disc Hernia |
Estimated Study Start Date : | March 1, 2017 |
Estimated Primary Completion Date : | January 1, 2018 |
Estimated Study Completion Date : | January 1, 2019 |

Group/Cohort | Intervention/treatment |
---|---|
ozone
Chemonucleolysis by ozone therapy Patients visiting the pain clinic of the hospital who had cervical discogenic or radicular pain that did not resolve after the use of conventional therapy. Written informed consent was obtained from all participants.
|
Drug: Ozone
Pain relief with chemonucleolysis by using ozone regard to age, sex, ASA score, and complications. |
- Visual analogue scale (VAS) score for pain [ Time Frame: 1 month ]Ozone therapy technique for pain relief assessed by Statistical Package for the Social Sciences (SPSS) v22.0 Statistical assessment of each patient was evaluated on time intervals before procedure, in the 1st month after procedure for Visual analogue scale (VAS) score for pain
- Oswestry Disability Index (ODI) score [ Time Frame: 3 months ]Assessment of degree of disability and estimating quality of life based on Oswestry Disability Index (ODI) score by SPSS v22.0 Statistical assessment of each patient was evaluated on time intervals before procedure, in the 3rd months after procedure for ODI score
- ODI score [ Time Frame: 1 month ]Assessment of degree of disability and estimating quality of life based on Oswestry Disability Index (ODI) score by SPSS v22.0 Statistical assessment of each patient was evaluated on time intervals before procedure, in the 1st month after procedure for ODI score

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- continuous radicular pain radiating to the upper limb, with a duration ≥8 weeks and an intensity >4/10 as rated by the patient on a visual analog scale (VAS)
- resistant to appropriate conservative treatment combining antiinflammatory drugs, and confirmed by imaging with CT or MRI of a herniated disc putting pressure on a nerve root consistent with the clinical pain.
Exclusion Criteria:
- history of surgery at the cervical spine, contraindication to percutaneous chemonucleolysis (coagulopathy or infection), imaging results that did not support the clinical results, the presence of a herniated disc excluded or calcified on imaging, possible interference with pain evaluation due to any medical condition or treatment, involvement of incomplete data collection

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03056911
Contact: Havva Sayhan, Assis Prof | +905056621021 | hsayhan@gmail.com | |
Contact: Serbülent Beyaz, AssocProf | +905322879490 | sgbeyaz@gmail.com |
Turkey | |
Sakarya University Research and Training Hospital | Recruiting |
Sakarya, Turkey, 54100 | |
Contact: Havva Sayhan, Assis Prof +905056621021 hsayhan@gmail.com | |
Contact: Serbülent Beyaz, Assoc Prof +90 264 8884051 ext 6166 sgbeyaz@gmail.com |
Study Chair: | Serbülent Beyaz, AssocProf | Sakarya University Research and Training Hospital |
Responsible Party: | Havva Sayhan, Assistant Professor, Sakarya University |
ClinicalTrials.gov Identifier: | NCT03056911 |
Other Study ID Numbers: |
sakarya Ozone |
First Posted: | February 17, 2017 Key Record Dates |
Last Update Posted: | February 17, 2017 |
Last Verified: | February 2017 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
ozone therapy percutaneous treatment Oswestry Disability Index (ODI) |
Visual analog Scale (VAS) Neuropathic Pain Questionnaire (DN-4) cervical |
Neck Pain Pain Neurologic Manifestations |